TUMOR PATIENTS

Clinical trials for TUMOR PATIENTS explained in plain language.

Never miss a new study

Get alerted when new TUMOR PATIENTS trials appear

Sign up with your email to follow new studies for TUMOR PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

A shield for bone marrow: can a drug stop Chemo's blood cell side effect?

Disease control Not yet recruiting

This trial tests whether a drug called trilaciclib can prevent myelosuppression — a drop in blood cell counts — caused by a type of chemotherapy known as topoisomerase I inhibitor antibody-drug conjugates (ADCs). About 96 cancer patients who are scheduled to receive these ADC dru…

Matched conditions: TUMOR PATIENTS

Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

TUMOR PATIENTS

Get alerted when new TUMOR PATIENTS trials appear

A shield for bone marrow: can a drug stop Chemo's blood cell side effect?